PerspectiveOsteoporosis

β-Arrestin–Biased Parathyroid Hormone Ligands: A New Approach to the Development of Agents that Stimulate Bone Formation

See allHide authors and affiliations

Science Translational Medicine  07 Oct 2009:
Vol. 1, Issue 1, pp. 1ps1
DOI: 10.1126/scitranslmed.3000268

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article